We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Jack in the Box
JACK
$329M
| $1.44M | 0.22% |
25,601
+11,560
| +82% | +$878K |
|
52
Clearfield
CLFD
$459M
| $1.42M | 0.21% |
+22,959
| New | +$1.35M |
|
|
WBA
53
DELISTED
Walgreens Boots Alliance
WBA
| $1.38M | 0.21% |
+36,500
| New | +$1.57M |
|
54
Linde
LIN
$223B
| $1.38M | 0.21% |
4,785
+755
| +19% | +$236K |
|
|
EPZM
55
DELISTED
Epizyme, Inc
EPZM
| $1.37M | 0.21% |
930,718
+462,882
| +99% | +$340K |
|
56
Regal Rexnord
RRX
$14.6B
| $1.36M | 0.2% |
+11,994
| New | +$1.53M |
|
57
Health Catalyst
HCAT
$168M
| $1.35M | 0.2% |
+93,315
| New | +$1.59M |
|
58
Targa Resources
TRGP
$56.4B
| $1.34M | 0.2% |
+22,470
| New | +$1.61M |
|
59
Triumph Financial Inc
TFIN
$1.91B
| $1.33M | 0.2% |
+21,246
| New | +$1.51M |
|
60
Altimmune
ALT
$597M
| $1.32M | 0.2% |
112,917
+83,434
| +283% | +$515K |
|
|
XIFR
61
XPLR Infrastructure LP
XIFR
$1.11B
| $1.31M | 0.2% |
17,676
+11,947
| +209% | +$857K |
|
62
CNO Financial Group
CNO
$5.14B
| $1.3M | 0.2% |
+72,113
| New | +$1.54M |
|
63
Hexcel
HXL
$7.88B
| $1.3M | 0.2% |
+24,945
| New | +$1.37M |
|
64
Uber
UBER
$147B
| $1.29M | 0.19% |
+63,078
| New | +$1.67M |
|
|
SF
65
Stifel
SF
$12.7B
| $1.28M | 0.19% |
34,364
+24,564
| +251% | +$1.02M |
|
|
AAT
66
American Assets Trust
AAT
$1.42B
| $1.28M | 0.19% |
43,167
+21,504
| +99% | +$720K |
|
67
Columbus McKinnon
CMCO
$622M
| $1.27M | 0.19% |
+44,713
| New | +$1.54M |
|
|
AIRC
68
DELISTED
Apartment Income REIT Corp.
AIRC
| $1.27M | 0.19% |
+30,424
| New | +$1.41M |
|
|
PACW
69
DELISTED
PacWest Bancorp
PACW
| $1.27M | 0.19% |
+47,497
| New | +$1.54M |
|
70
Barnes & Noble Education
BNED
$447M
| $1.25M | 0.19% |
+4,263
| New | +$1.24M |
|
71
Arlo Technologies
ARLO
$1.73B
| $1.25M | 0.19% |
199,004
+94,549
| +91% | +$692K |
|
72
Hancock Whitney
HWC
$6.32B
| $1.24M | 0.19% |
+28,028
| New | +$1.33M |
|
73
MSC Industrial Direct
MSM
$7.08B
| $1.24M | 0.19% |
+16,522
| New | +$1.36M |
|
|
SAFM
74
DELISTED
Sanderson Farms Inc
SAFM
| $1.23M | 0.18% |
5,710
+3,921
| +219% | +$768K |
|
75
Berkshire Hathaway Class A
BRK.A
$1.11T
| $1.23M | 0.18% |
3
+2
| +200% | +$942K |
|
Similar funds
ACB
SCI
SCM
BW
HH
KCM
PRA
CC
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.